Guidance Archives - Page 111 of 637

1 minute read

Dynatrace Raises FY24 Outlook: Revenue $1.485B-$1.495B ($1.48B-$1.49B Prior) Vs. $1.417B Estimate, Adj. EPS $1.16-$1.18 ($1.09 – $1.12 Prior) Vs, $1.11 Estimate

By Benzinga Newsdesk

February 8, 7:36 AM

(In millions, except per share data) Current Guidance Fiscal 2024 Prior Guidance Fiscal 2024* Guidance

2 minute read

Thomson Reuters Expects FY24 Revenue Growth of ~ 6.5% Vs $7.19B Est and Organic Revenue Growth of ~ 6%, Q1 Organic Revenue Growth of ~8%

By Benzinga Newsdesk

February 8, 7:35 AM

2024 Outlook The company's outlook for 2024 in the table below assumes constant currency rates and incorporates the recent Pagero and World Business Media acquisitions but excludes the impact of

TRI

1 minute read

Dynatrace Q4 Outlook: Revenue $372M – $377M Vs. $373.46M Estimate, Adj. EPS $0.26 – $0.28 Vs. $0.25 Estimate

By Benzinga Newsdesk

February 8, 7:34 AM

All growth rates below are compared to the fourth quarter and full year of fiscal 2023. (In millions, except per share data) Q4 Fiscal

2 minute read

Why Personal Products Major Unilever Shares Are Rising Today

By Lekha Gupta

February 8, 7:28 AM

Unilever's FY24 performance shines with a 7.0% underlying sales growth, buoyed by strategic pricing and volume enhancements. The company's 42.2% gross margin surge underscores its adept cost management and productivity boosts.

2 minute read

Confluent Shares Surge On Q4 Earnings: The Details

By Adam Eckert

February 7, 5:50 PM

Confluent Inc (NASDAQ:CFLT) shares are trading higher in Wednesday's after-hours session on the heels of the company's fourth-quarter results. Here's a rundown of the report.

CFLT

2 minute read

PayPal Q4 Earnings: Revenue Beat, EPS Beat, Payment Volumes Up 15%, Active Accounts Down 2%, Soft Guidance And More

By Adam Eckert

February 7, 5:33 PM

PayPal's fourth-quarter revenue increased 9% year-over-year to $8.03 billion, which beat the consensus estimate of $7.87 billion, according to Benzinga Pro. The company reported quarterly adjusted earnings of $1.48 per share, which beat analyst estimates of $1.36 per share.

PYPL

2 minute read

Analysts Boost Eli Lilly’s Forecast With High Hopes On Mounjaro, Zepbound Performance

By Vandana Singh

February 7, 3:49 PM

Eli Lilly's SYNERGY-NASH Phase 2 study results and positive market outlook drive BMO's raised price target to $865. Morgan Stanley remains bullish on Mounjaro/Zepbound launch. BofA Securities cites growth potential.

LLY

2 minute read

Investors’ Focus Around Amgen’s Obesity Drug Data Shadows Better Than Expected Q4 Earnings

By Vandana Singh

February 7, 3:36 PM

Amgen's Q4 2023: 15% net profit growth, $8.2 billion total revenues beat expectations. Prolia leads with 12% sales jump. Analysts' reactions and price targets.

AMGN

1 minute read

Bunge Q4 Sales Falls Over 10%, CEO Cautions Of ‘Less Robust Market Environment’

By Nabaparna Bhattacharya

February 7, 2:49 PM

Bunge's Q4 sales drop 10%, but beat EPS estimates; CEO warns of a less favorable market environment in 2024, projecting full-year earnings lower than estimate.

2 minute read

Performance Food Group Q2 Bottomline Miss Estimates Owing To Decrease In Selling Price: Details

By Nabaparna Bhattacharya

February 7, 2:23 PM

Performance Food Group disappoints in Q2 earnings, citing decreased selling prices, despite marginal sales growth.

PFGC